切换至 "中华医学电子期刊资源库"

中华细胞与干细胞杂志(电子版) ›› 2018, Vol. 08 ›› Issue (01) : 17 -21. doi: 10.3877/cma.j.issn.2095-1221.2018.01.004

所属专题: 文献

论著

ALDH1蛋白表达与胶质瘤干细胞体外分化相关性的研究
王鹏1, 宋伟正1, 毛庆2, 陈米娜3, 刘艳辉2,()   
  1. 1. 611130,成都市第五人民医院神经外科
    2. 610041 成都,四川大学华西医院神经外科
    3. 610041 成都,四川大学华西医院生物治疗国家重点实验室
  • 收稿日期:2018-01-05 出版日期:2018-02-01
  • 通信作者: 刘艳辉
  • 基金资助:
    国家自然科学基金资助项目(30873007)

Relationship between ALDH1 expression and cell differentiation of glioma stem cells in vitro

Peng Wang1, Weizheng Song1, Qing Mao2, Mina Chen3, Yanhui Liu2,()   

  1. 1. Department of Neurosurgery, the Fifth People's Hospital of Chengdu, Chengdu 611130, China
    2. Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu 610041, China
    3. State Key Laboratory of the Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China
  • Received:2018-01-05 Published:2018-02-01
  • Corresponding author: Yanhui Liu
  • About author:
    Corresponding author: Liu Yanhui, Email:
引用本文:

王鹏, 宋伟正, 毛庆, 陈米娜, 刘艳辉. ALDH1蛋白表达与胶质瘤干细胞体外分化相关性的研究[J]. 中华细胞与干细胞杂志(电子版), 2018, 08(01): 17-21.

Peng Wang, Weizheng Song, Qing Mao, Mina Chen, Yanhui Liu. Relationship between ALDH1 expression and cell differentiation of glioma stem cells in vitro[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2018, 08(01): 17-21.

目的

探讨乙醛脱氢酶1(ALDH1)蛋白表达与胶质瘤干细胞体外分化相关性。

方法

将原代培养的胶质瘤干细胞分为分化组与对照组,分化组细胞使用10%的胎牛血清诱导,对照组细胞继续在无血清环境中培养,通过免疫荧光细胞化学染色和Western blot观察两组细胞ALDH1蛋白的表达情况,分别使用Wilcoxon符号秩检验和配对样本t检验分析两组ALDH1阳性细胞率和相对蛋白含量的差异。

结果

分化组细胞呈完全贴壁生长,异型性明显,对照组细胞呈团状聚集,形态较为均一。两组的ALDH1阳性细胞率分别为:分化组18.78%?±?6.03%,对照组81.23%±?3.19%;ALDH1相对蛋白含量分别为:分化组0.035±0.009,对照组0.390±0.108。两组的阳性细胞率和相对蛋白含量比较差异具有统计学意义(Z = -2.666,P = 0.008;t = -10.637,P = 0.000)。

结论

本实验通过半定量研究进一步证实了在体外培养状态下,ALDH1主要存在于较为原始的肿瘤细胞中,分化后几乎不表达,提示ALDH1作为可能的胶质瘤干细胞标志物仍有进一步研究的价值。

Objective

To evaluate the relationship between the expression of ALDH1 protein and cell differentiation of glioma stem cells in vitro.

Methods

The primary cultured glioma stem cells were divided into the differentiation group and the control group. The cells in the differentiation group were induced by 10% fetal bovine serum, and the cells in the control group were cultured in the serum-free medium. Immunofluorescence staining and Western blot were used to observe protein expression of ALDH1, and differences of positive cells and relative protein content between the two groups were analyzed by Wilcoxon signed-rank test and paired sample t test.

Results

The cells in the differentiation group were multiform and completely adhered, and in the control group they were clustered together with uniform morphology. The rate of ALDH1 positive cells in the differentiation group and control group were 18.78%±6.03% and 81.23%±3.19% respectively, and relative protein content in the two groups were 0.035±0.009 and 0.390±0.108 respectively. Statistical analysis showed that there was significant difference of positive cell rate and relative protein content between the two groups (Z = -2.666, P = 0.008; t = -10.637, P?= 0.000).

Conclusions

This semi quantitative study further confirmed that ALDH1 was mainly existed in relatively primitive tumor cells and almost not expressed after differentiation, suggesting that ALDH1 is a potential glioma stem cell marker.

图1 倒置显微镜下观察分化组与对照组细胞形态
表1 分化组与对照组细胞ALDH1蛋白的表达情况(±s
图2 荧光显微镜下观察分化组与对照组细胞ALDH1蛋白的表达(×200)
图3 分化组与对照组中各细胞标本ALDH1阳性细胞率的比较
图4 Western blot检测分化组与对照组细胞的ALDH1相对蛋白含量
1
Batash R, Asna N, Schaffer P, et al. Glioblastoma multiforme, diagnosis and treatment; recent literature review[J]. Curr Med Chem, 2017, 24(27):3002-3009.
2
Auffinger B, Spencer D, Pytel P, et al. The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence[J]. Expert Rev Neurother, 2015, 15(7):741-752.
3
Rasper M, Schaefer A, Piontek G, et al. Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity[J]. Neuro Oncol, 2010, 12(10):1024-1033.
4
Adam SA, Schnell O, Poeschl J, et al. ALDH1A1 is a marker of astrocytic differentiation during brain development and correlates with better survival in glioblastoma patients[J]. Brain Pathol, 2012, 22(6):788-797.
5
王鹏,毛庆,王翔, 等. 胶质母细胞瘤中CD133+细胞的贴壁培养和乙醛脱氢酶1的表达[J]. 四川大学学报(医学版), 2011, 42(3):413-416.
6
Flahaut M, Jauquier N, Chevalier N, et al. Aldehyde dehydrogenase activity plays a key role in the aggressive phenotype of neuroblastoma[J]. BMC Cancer, 2016, 16(1):781.
7
Tomita H, Tanaka K, Tanaka T, et al. Aldehyde dehydrogenase 1A1 in stem cells and cancer[J]. Oncotarget, 2016, 7(10):11018-11032.
8
Roudi R, Korourian A, Shariftabrizi AA. Differential expression of cancer stem cell markers ALDH1 and CD133 in various lung cancer subtypes[J]. Cancer Invest, 2015, 33(7):294-302.
9
Dolle L, Best J, Empsen C, et al. Successful isolation of liver progenitor cells by aldehyde dehydrogenase activity in naive mice[J]. Hepatology, 2012, 55(2):540-552.
10
Yang L, Ren Y, Yu X, et al. ALDH1A1 defines invasive cancer stem-like cells and predicts poor prognosis in patients with esophageal squamous cell carcinoma[J]. Mod Pathol, 2014, 27(5):775-783.
11
Wang YC, Yo YT, Lee HY, et al. ALDH1-Bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome[J]. Am J Pathol, 2012, 180(3):1159-1169.
12
Choi SA, Lee JY, Phi JH, et al. Identification of brain tumour initiating cells using the stem cell marker aldehyde dehydrogenase[J]. Eur J Cancer, 2014, 50(1):137-149.
13
Lu HX, Yang ZQ, Jiao Q, et al. Low concentration of serum helps to maintain the characteristics of NSCs/NPCs on alkali-treated PHBHHx film in vitro[J]. Neurol Res, 2014, 36(3):207-214.
14
Zhou XP, Zheng C, Shi Q, et al. Isolation, cultivation and identification of brain glioma stem cells by magnetic bead sorting[J]. Neural Regen Res, 2012, 7(13):985-992.
15
Pollard SM, Yoshikawa K, Clarke ID, et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens[J]. Cell Stem Cell, 2009, 4(6):568-580.
[1] 刘星辰, 刘娟, 魏宝宝, 刘洁, 刘辉. XIAP与XAF1异常表达与卵巢癌的相关性分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 419-427.
[2] 尹娟, 杨兴, 李平, 徐旻馨, 鲍玉, 张志鹏, 薛慧. 低强度脉冲式超声波在脂多糖诱导的RAW264.7巨噬细胞分化中的抗炎和抗氧化作用[J]. 中华口腔医学研究杂志(电子版), 2023, 17(01): 26-36.
[3] 刘娜, 赵然然. 支气管哮喘微量元素水平与免疫功能的相关性分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(01): 74-76.
[4] 甘开梅, 黄剑. 肺癌干细胞对EGFR-TKI耐药影响的研究进展[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(01): 36-44.
[5] 李婧娴, 韩兴龙, 涂元媛, 胡士军, 于淼, 雷伟. 内皮祖细胞在血管损伤修复中的研究进展[J]. 中华细胞与干细胞杂志(电子版), 2022, 12(03): 176-180.
[6] 王继荣, 暴一众, 唐颖, 吕晓玲, 杨舟鑫. 吴茱萸碱抑制破骨细胞分化延缓骨丢失的研究[J]. 中华细胞与干细胞杂志(电子版), 2022, 12(02): 86-92.
[7] 刘伟华, 赵宇, 刘仲凤, 吴焕童, 张广吉, 陈志国. 神经干细胞生物制剂治疗中枢神经系统恶性肿瘤的研究进展[J]. 中华细胞与干细胞杂志(电子版), 2022, 12(01): 59-62.
[8] 欧苏文, 罗康佳, 管子龙, 黄睿. MicroRNAs调控结直肠癌干细胞的研究进展[J]. 中华结直肠疾病电子杂志, 2021, 10(03): 306-312.
[9] 冯巍, 袁喜平, 胡丙宇, 刘金涛, 商东升. 外伤后进展性胶质母细胞瘤一例报道并文献复习[J]. 中华神经创伤外科电子杂志, 2022, 08(01): 59-60.
[10] 周兴旺, 刘艳辉. 老年胶质母细胞瘤的治疗进展[J]. 中华神经创伤外科电子杂志, 2021, 07(06): 321-324.
[11] 孙明阳, 刘艳坤, 陈思, 李玉凤, 李玉辉. NHE1抑制剂改善胶质母细胞瘤细胞对替莫唑胺耐药性的研究[J]. 中华神经创伤外科电子杂志, 2021, 07(05): 261-265.
[12] 林发牧, 邓燕婷, 梁玉明, 简志聪, 邓妙峰, 陈耿树, 麦剑培, 钱卫添, 元少鹏, 胡建军. CLSPN在胶质瘤中的表达及生物学功能[J]. 中华神经创伤外科电子杂志, 2021, 07(04): 235-241.
[13] 张婵, 薛强, 田锐锋, 陈晓燕. Kir4.1在恶性胶质瘤中的表达及其潜在作用:数据库结合文献分析[J]. 中华神经创伤外科电子杂志, 2021, 07(04): 224-234.
[14] 贾伟强, 王兆涛, 徐如祥. 毛蕊花糖苷上调SHP1表达抑制STAT3磷酸化治疗胶质母细胞瘤的分子机制研究[J]. 中华脑科疾病与康复杂志(电子版), 2021, 11(05): 285-293.
[15] 叶飞龙, 杨冠英, 王伟. 对流增强给药治疗胶质母细胞瘤的研究进展[J]. 中华脑血管病杂志(电子版), 2021, 15(05): 287-292.
阅读次数
全文


摘要